Oculoplastic Surgery Market Size, Share & Trends Analysis Report By Product (Instruments, Implants & Grafts, Equipment), By Procedure (Eyelid Surgery, Face Lift, Orbital Surgery), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Oculoplastic Surgery Market Size & Trends

The global oculoplastic surgery market size was estimated at USD 9.31 billion in 2023 and is projected to grow at a CAGR of 6.05% from 2024 to 2030. The increasing number of older individuals and advancements in technologies employed in the products that are used in oculoplastic procedures are anticipated to propel market growth over the forecast period. For instance, the India Ageing Report 2030 estimated that approximately USD 347 million individuals in India will be aged 60 or above by 2050.

Technological advancements, such as the adoption of radiofrequency-assisted and laser-assisted blepharoplasty, are expected to boost market growth. Novel lasers are being used to enhance the surgical outcomes of oculoplastic surgery. For instance, Rohrer Aesthetics, Inc. offers the PIXEL8 PRO laser system for laser blepharoplasty. This device offers improved precision and lowers the risk of complications during eyelid surgery. Thus, the availability of such technologically advanced products for oculoplastic surgeries is projected to support the segment growth.

In addition, the increasing number of older individuals across the globe is anticipated to boost demand for oculoplastic surgery as the senior population is at higher risk of developing eye-related problems such as drooping eyebrows & eyelids, sagging skin, and ptosis. According to an article by the WHO in October 2022, almost 2.1 billion people will be 60 years and older by 2050. Moreover, a significant number of older people are adopting oculoplastic procedures. For instance, individuals over 70 received 13 % of total eyelid surgeries in 2022, as per the 2022 Plastic Surgery Statistics Report by the American Society of Plastic Surgeons. Thus, rising number of older individuals, coupled with the growing adoption of oculoplastic procedures among this age group, is anticipated to boost market growth.

Market Concentration & Characteristics

The industry growth stage is medium, and the pace of the industry growth is accelerating due to the rising demand for oculoplastic surgeries and increasing focus of industry participants on expanding the product portfolio for these surgeries.

The degree of innovation is high due to increase in funding for innovative products and development of advanced products. Established and emerging companies are innovating continuously to offer better products. For instance, in February 2024, Aesthetic Management Partners (AMP) launched the first fractional plasma device, Plasmage, for aesthetic procedures. This device is useful for blepharoplasty procedures. Such innovations are expected to fuel industry growth over the forecast period.

Several industry participants are undergoing mergers and acquisitions to strengthen their presence in the industry. For instance, in April 2022, Carl Zeiss Meditec AG, a company offering products for oculoplastic surgery, purchased two surgical instrument manufacturers- Katalyst Surgical, LLC and Kogent Surgical, LLC. Numerous surgical instruments such as forceps, scissors, spoons, and blades are used in oculoplastic surgeries.

Regulations are governed by regulatory organizations such as the Food and Drug Administration (FDA) in the U.S. and equivalent authorities across the world. The agencies have published a regulatory framework to assure the effectiveness, safety, and quality of the products used in oculoplastic surgeries. In addition, these authorities are involved in marketing and offering patents for innovative devices used in oculoplastic procedures. For instance, ZIPLYFT is a patented FDA Class 1 device from the OSHERU for eyelid surgeries.

Nonsurgical devices, equipment, & topical solutions for several eye conditions, such as eye drooping and blepharoplasty, can act as substitutes to the products in the market.

Several small, medium, and established players represent the market. Established companies such as Integra LifeSciences Corporation, Stryker, and Bausch + Lomb offer various products. In addition, emerging players like RUMEX International Inc. and Bolton Surgical Ltd are focusing on expanding their presence in various regions.

Some of the industry players undertaking regional expansion are Surgical Holdings, Stryker, and BVI Medical. This helps the companies increase the reach of their products in numerous regions and countries.

Products Insights

The instruments segment accounted for the largest revenue share of 45.87% in 2023 due to the wide usage of these instruments in several oculoplastic surgeries, like eyelid surgery, facelifts, and brow lifts, among others. Furthermore, the availability of instruments, such as scissors, forceps, clamps, etc., from key participants such as Integra LifeSciences Corporation, Surgical Holdings, and FCI is expected to boost segment growth in the coming years. The implants & grafts segment is anticipated to grow at the highest CAGR over the forecast period. Grafts are primarily used to reconstruct one or both eyelid structures. Moreover, implants provide adequate volume reinstatement and revamp the cosmetic look of a normal eye during oculoplastic surgeries. Thus, the demand for implants & grafts is anticipated to increase with the rising number of oculoplastic procedures being performed globally.

Procedure Insights

The eyelid surgery segment dominated the market with a revenue share of 37.82% in 2023. The rising adoption of this surgery in developed and emerging countries is anticipated to boost segment growth. According to an article by Johns Hopkins University, over 100,000 men and women in the U.S. undergo cosmetic eyelid lifts every year. In addition, as per the International Society of Aesthetic Plastic Surgery, 81,419 eyelid surgeries were conducted in Mexico in 2022.

The brow lift/forehead lift segment is expected to witness the fastest CAGR over the forecast period. This growth can be attributed to increasing awareness about the benefits of oculoplastic surgeries, such as brow lifts, among healthcare professionals and the public. Furthermore, many individuals opting for brow lifts are anticipated to propel segment growth. According to a report issued by the International Society of Aesthetic Plastic Surgery, approximately 352,324 brow lift procedures were conducted worldwide in 2022.

End-use Insights

The Ambulatory Surgical Centers (ASCs) segment accounted for the largest market share of 65.1% in 2023. It is also anticipated to grow at the fastest rate over the forecast period. Growing preference for same-day surgeries and rising demand for oculoplastic procedures are anticipated to propel the segment growth. In addition, advantages such as lower cost and shorter wait time associated with these surgical centers are expected to boost the segment growth.

The hospitals and clinics segment is anticipated to grow at a significant CAGR during the forecast period due to the rising number of hospitals and a growing number of individuals visiting ophthalmic clinics in emerging markets. According to the American Hospital Association, as of 2024, there were 6,120 hospitals in the U.S. Thus, the availability of a large number of hospitals is projected to boost the segment growth.

Regional Insights

The North America oculoplastic surgery market dominated the global market in 2023, accounting for 29.61% of the revenue share. The market growth can be attributed to the rising prevalence of eye diseases, such as eyelid malposition, ptosis, and tear duct conditions, among aging people. Moreover, the region is witnessing a significant increase in adoption of oculoplastic surgeries. For instance, according to the 2022 Plastic Surgery Statistics Report, facelift procedures had a significant of 8% growth in 2022.

U.S. Oculoplastic Surgery Market Trends

The oculoplastic surgery market in the U.S. accounted for largest share of the North American region in 2023 due to the increasing number of minimally invasive surgeries in aesthetics and availability of technologically advanced techniques & products that are used in these procedures. In addition, presence of major participants like Matrix Surgical USA, Integra LifeSciences Corporation.,Stryker and RUMEX International Co. in the U.S. is projected to support growth.

Europe Oculoplastic Surgery Market Trends

The oculoplastic surgery market in Europe is anticipated to show significant growth in this industry due to the rising geriatric population across European countries. In addition, the adoption of oculoplastic procedures in Europe is growing with increasing awareness about the advantages of these procedures.

The UK oculoplastic surgery market is anticipated to grow over the forecast period primarily due to the presence of key industry participants such as Surgical Holdings and Bolton Surgical Ltd. These participants have a wide range of products, such as scissors, calipers, retractors, and forceps, which can be used during ophthalmic procedures.

The oculoplastic surgery market in France expected to grow over the forecast period due to the increasing societal focus on personal appearance & beauty standards and advancing medical technology & surgical techniques. In addition, growing disposable income and changing lifestyle have played a pivotal role in driving the adoption of oculoplastic & aesthetic procedures across the country.

The Germany oculoplastic surgery market is expected to grow over the forecast period due to increasing aging population and rising number of cosmetic procedures. For instance, around 1,032,791 surgical and nonsurgical cosmetic procedures were conducted in Germany in 2022.

Asia Pacific Oculoplastic Surgery Market Trends

The oculoplastic surgery market in Asia Pacific is anticipated to witness the fastest growth during the forecast period. This growth is driven by growing geriatric population and rising awareness & acceptance of oculoplastic surgery. Furthermore, the increase in prevalence of oculoplastic problems, such as tear duct disorders and eyelid malposition, drive the need for corrective surgeries.

The Japan oculoplastic surgery market is expected to grow significantly in the coming years. Rising number of oculoplastic surgeries being performed across the country is anticipated to drive the market demand. According to the statistics published by the International Society of Aesthetic Plastic Surgery, around 74,819 facelift procedures were conducted in Japan.

The oculoplastic surgery market in China is expected to grow over the forecast period due to the rising awareness and acceptance of oculoplastic surgery among the Chinese population and the growing number of older individuals across the country. According to the study published by BioMed Central Ltd in June 2023, the population of those aged 65 & older is estimated to reach 366 million by 2050 in China.

The India oculoplastic surgery market is expected to grow significantly in the coming years due to increasing adoption of oculoplastic procedures in the country and a rising aging population. For instance, according to the International Society of Aesthetic Plastic Surgery Global Survey 2022, approximately 30,067 eyelid surgeries and 5,737 facelift procedures were conducted in India.

Middle East & Africa Oculoplastic Surgery Market Trends

The oculoplastic surgery market in Saudi Arabia is anticipated to grow over the forecast period due to high number of surgical procedures being undertaken, the presence of well-trained oculoplastic surgeons, and the rising number of older individuals across the country.

The Kuwait oculoplastic surgery market is expected to grow in the coming years due to increasing awareness among the Kuwaiti population about the advantages of oculoplastic procedures and rising number of surgical procedures nationwide.

Key Oculoplastic Surgery Company Insights

The small, medium, and established players drive the competition in the oculoplastic surgery market. These players are adopting various strategies such as partnerships, innovative product launches, and mergers & acquisitions. Some of the key players operating in the market are Bausch + Lomb, Carl Zeiss Meditec AG, Stryker, and Integra LifeSciences Corporation.

• Integra LifeSciences Corporation is a major player in the medical device industry and offers a wide range of products for neurological & surgical applications. The company focuses on neurological conditions like brain tumors, traumatic brain injury, hydrocephalus, and hemorrhagic stroke.

• ZEISS provides a full range of tools for diagnosing and treating eye diseases. The company specializes in microsurgery and develops innovative visualization systems to aid surgeons. ZEISS focuses on ophthalmology (eye care), ophthalmic surgery (eye surgery), and microsurgical visualization systems.

• Bausch + Lomb is one of the major players in the global eye health industry. It has a significant presence around the world, with research, development, manufacturing, and sales operations in nearly 100 countries and employs around 13,000 people. Its product range is vast, with over 400 items that cover all aspects of eye care.

Recent Developments

• In September 2023, BVI Medical, a key industry player, reported the acquisition of Medical Mix, which provides medical devices for ophthalmic surgery across Portugal and Spain.

• In July 2023, Patricia Buehler, a founder of the company that develops the Ziplyft device, won first place in Winning Pitch Challenge for Ziplyft during Eyecelerator in the U.S. Ziplyft is an eyelid surgery device used to remove excess skin from the upper lid in 10 minutes. This device helps perform procedures without IV sedation and reduces postoperative bruising & swelling. Such technological advancement by emerging participants is anticipated to propel market growth.

• In June 2022, FCI, a major market participant, introduced OCULID-a comprehensive solution for lagophthalmos. OCULID also includes OCULID Gold implants.

Oculoplastic Surgery Market Report Scope 

Global Oculoplastic Surgery Market Report Segmentation

This report forecasts revenue growth at the global, regional, & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global oculoplastic surgery market report based on product, procedure, end-use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Instruments

    • Forceps

    • Knife Handles and Blades

    • Scissors

    • Needle Holders

    • Clamps

    • Hooks and Retractors

    • Others

  • Implants & Grafts

  • Equipment

• Procedure Outlook (Revenue, USD Million, 2018 - 2030)

  • Eyelid Surgery

  • Facelift

  • Brow Lift/ Forehead Lift

  • Pediatric Oculoplastic Surgery

  • Orbital surgery

• End - use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals and Clinics

  • Ambulatory Surgical Centers

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Norway

    • Sweden

    • Denmark

  • Asia Pacific

    • China

    • Japan

    • India

    • Thailand

    • South Korea

    • Australia

  • Latin America

    • Mexico

    • Brazil

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait